Novartis India Limited (BOM:500672)
1,414.25
+52.65 (3.87%)
At close: May 26, 2026
Novartis India Market Cap
Novartis India has a market cap or net worth of 34.92 billion as of May 27, 2026. Its market cap has increased by 80.84% in one year.
Market Cap
34.92B
Enterprise Value
28.27B
Revenue
3.54B
Ranking
n/a
PE Ratio
37.47
Stock Price
1,414.25
Market Cap Chart
Since April 14, 1999, Novartis India's market cap has increased from 12.59B to 34.92B, an increase of 177.46%. That is a compound annual growth rate of 3.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 34.92B | 81.55% |
| Dec 31, 2025 | 19.23B | -15.31% |
| Dec 31, 2024 | 22.71B | 18.95% |
| Dec 29, 2023 | 19.09B | 14.56% |
| Dec 30, 2022 | 16.67B | -12.94% |
| Dec 31, 2021 | 19.14B | 13.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sanofi India | 72.89B |
| FDC Limited | 60.79B |
| Bliss GVS Pharma | 31.76B |
| Gufic Biosciences | 29.38B |
| Unichem Laboratories | 26.21B |
| Hikal | 25.28B |
| Morepen Laboratories | 23.51B |
| Kwality Pharmaceuticals | 22.15B |